Although the lung is the most common metastatic site for cancer cells, biological mechanisms regulating lung metastasis are not fully understood. Using heterotopic and intravenous injection models of lung metastasis in mice, we found that IL-5, a cytokine involved in allergic and infectious diseases, facilitates metastatic colonization through recruitment of sentinel eosinophils and regulation of other inflammatory/immune cells in the microenvironment of the distal lung. results establish a network of allergic inflammatory circuitry that can be co-opted by metastatic cancer cells to facilitate lung colonization, suggesting interventions to target this pathway may offer therapeutic benefits to prevent or treat lung metastasis.
Introduction
Most cancer deaths occur due to metastatic disease and its complications, and the lungs are the most common metastatic site for a variety of cancers (1) . Metastasis is a complex multistep process, which includes detachment of malignant cells from the primary tumor, intravasation and circulation of malignant cells in the bloodstream, extravasation in the target organs, degradation of extracellular matrix, and colonization in the target organ (2) . Although the majority of malignant cells never reach the invasion and colonization stages due to immune surveillance, some cells develop the ability to escape immune control and invade distant organs, including the lungs. To avoid the host immune system, cancer cells can "educate" immune cells to support metastases within the pulmonary microenvironment through secretion of cytokines.
However, specific cellular and molecular mechanisms by which immune/inflammatory cells support invasion, survival, and proliferation of malignant cells are incompletely understood.
Cytokines are essential in sculpting the tumor microenvironment and have been implicated in regulation of tumor growth and progression. To this end, the role of Th2 cytokines is increasingly appreciated (3) . Interleukin-5 (IL-5) is a Th2 cytokine produced mainly by lymphocytes and to a lesser degree by mast cells, type 2 innate lymphoid (ILC2) cells, and eosinophils (4, 5) . IL-5 was originally shown to stimulate antibody production by activated B cells (6) , but more recently has become known as a major factor in eosinophil differentiation and proliferation. IL-5 has been implicated in the pathogenesis of asthma, atopy, hypereosinophilic syndromes, and parasitic infections (7, 8) . In addition, IL-5 appears to have a role in cancer biology, but existing evidence is contradictory. We previously reported that IL-5 does not alter lung tumor formation after treatment with the carcinogen urethane (9) ; however, we found that disease (10) . In contrast, other studies have found that IL-5 facilitates immune surveillance against carcinogen-induced fibrosarcoma and melanoma (11, 12) . In humans, elevated serum IL-5 levels and excessive eosinophilia have been detected in patients with advanced stage non-small cell lung cancer (13) . These data led us to investigate a possible contribution of IL-5 to tumor cell metastasis in the lungs. By employing a variety of preclinical models of metastasis, we found that IL-5 is a pivotal factor in determining metastatic colonization of the lungs. 
Materials and Methods

Mouse models
All animal care and experimental procedures were approved by the Vanderbilt University Institutional Animal Care and Use Committee. Sex-, weight-, and age-matched 8-to 10-wk-old wild type C57BL/6 mice, IL-5-deficient mice (C57BL/6-Il5 tm1Kopf /J, hereafter called IL-5KO) mice (9) , c-kit mutant mice (B6.Cg-Kit W-sh /HNihrJaeBsmGlliJ, hereafter called c-kit W-sh ) (14) were used. For intravenous (IV) metastasis models, Lewis lung adenocarcinoma (LLC, 1. as well as lung metastases were assessed 28 days later. At the time of harvest, lungs were fixed in Bouin's fixative solution (Sigma-Aldrich) for 24 hours and surface tumors were counted as previously described (16) . Tumor diameters were determined using digital calipers (Fisher Scientific).
Reconstitution or neutralization of IL-5 in vivo
To reconstitute IL-5 in IL-5KO mice, 50 ng rmIL-5 (R&D) in 100 ml phosphate-buffered saline (PBS) or PBS alone was delivered to mice by intraperitoneal (IP) injection every other day for 4 days prior to IV injection of LLC cells or every other day starting the day of tumor cell injection until harvest at day 14 (17) . For IL-5 neutralization studies, mice received weekly IV injections of mouse IL-5 mAb (Clone TRFK5, R&D) (1 mg/kg) or isotype control (IgG) antibodies with the first dose given 3 hours prior to injection of tumor cells.
Measurement of IL-5 protein
Concentration of IL-5 protein in mouse lung, blood and bone marrow was determined using ELISA (R&D).
Cell proliferation
After seeding equal numbers of LLC cells into 96-well plates, the CellTiter-Glo® assay (Promega) was used to measure viable cells during different intervals of culture in the presence of rmIL-5 (10 ng/ml, R&D) or IL-5 antibodies (5 ng/ml, R&D).
Fluorescent microscopy and immunohistochemistry
For studies to detect LLC cells in the lungs, cells were stained with CellTracker™ Red CMTPX (Molecular Probes) prior to IV injection and lungs were harvested 24 hours later. Using
Metamorph software, LLC cells were counted on 4 randomly selected fields of lung parenchyma (20x magnification) and divided by the total area of lung tissue measured using Metamorph software. For detection of eosinophils, 5 µm lung sections were immunostained with rat antimouse MBP-1 monoclonal antibody (from Dr. James Lee, Mayo Clinic, Scottsdale, AZ) and detected using diaminobenzidene-peroxidase reagents and methyl green counterstain (18) . MBP-1 + eosinophils were counted on 10 randomly selected fields of lung parenchyma at 20x magnification. Isolation of lung cells for flow cytometry was performed using a previously described protocol (19) . Cells were stained with the following antibodies: CD4 -FITC, CD25 -APC, MHC-IIbiotin (e-Bioscience), CD45 -APC-Cy7, FoxP3 -PE, CD19 -PerCP-Cy5.5, CD11c -Brilliant Violet 605, Siglec-F -Brilliant Violet 421, CD49b -Brilliant Violet 421, CD206 -APC (Biolegend), CD3 -PE-Cy7, CD8 -Alexa Fluor 700, IFNγ -APC (BD Bioscience), CCR3 -APC (R&D), CD68 -FITC (AbD Serotec) and F4/80 -PE (Life Technologies). Dead cells were excluded using Live/Dead Fixable Blue Dead Cell Stain kit (Life Technologies). For determining production of IFNγ, lung cells were stimulated with PMA (1ng/ml) and ionomycin (1uM) for 6 hours in the presence of Golgi-stop (BD Biosciences) at 37°C, 5% CO2. After staining for surface markers, cells were permeabolized and processed for intracellular staining using anti-IFNγ or anti-IL-4 antibodies. Flow cytometry was performed using BD LSR II flow cytometer (BD Bioscience) and data were analyzed with FlowJo software (TreeStar).
Flow Cytometry
Adoptive transfer of eosinophils
Bone marrow derived eosinophils (BMDEos) were obtained as described (20) and 5 x 10 6 cells were injected via the tail vein 1 hour prior to injection of LLC cells.
Real-Time (RT) PCR
Total RNA was isolated from lung tissue using the RNeasy Mini kit (Qiagen) according to 
In vivo CCL22 and Treg cell depletion
Results
IL-5 promotes metastasis to the lungs
To investigate whether IL-5 affects lung metastasis, we utilized a heterotopic model in which we injected Lewis lung carcinoma (LLC) cells (2. 
IL-5 facilitates pulmonary metastasis by regulating eosinophils in the lungs
We postulated that immune/inflammatory cells regulated by IL-5 might facilitate pulmonary metastasis. Since IL-5 promotes recruitment and expansion of tissue eosinophils (7, 8) , we analyzed lungs from WT and IL-5KO mice for infiltration with eosinophils. We Figures 4C-D) . To confirm these findings, we performed flow cytometry analysis of lung eosinophils from WT and IL-5KO mice at days 0, 1, and 3 after IV injection of LLC cells. We identified eosinophils as cells expressing CD45, Siglec-F, and F4/80, but not CD11c (21) (22) (23) . These eosinophils expressed high levels of CCR3, low levels of Gr1, and were negative for CD68 (Supplementary Figure S1) as previously reported (24) . As shown in To test whether eosinophils play an important role in lung metastasis, we differentiated normal eosinophils from bone-marrow progenitor cells of WT mice using published protocols (20) and performed adoptive transfer of these cells to WT and IL-5KO mice. The purity of cultured bone marrow-derived eosinophils (BMDEos) was confirmed to be >98% by analysis of cell morphology ( Figure 4G ). WT and IL-5KO mice received BMDEos (5x10 6 ) by IV injection one hour prior to IV injection of LLC. We chose this timing for injection of BMDEos because of the relatively short in vivo half-life of these cells (20) . Adoptive transfer of BMDEos resulted in a large (3-fold) increase in lung metastases in IL-5KO mice while WT mice showed a trend towards increased numbers of pulmonary metastases (p=0.07) ( Figure 4H ). Based on these results, we concluded that eosinophils are important for IL-5-mediated promotion of pulmonary metastasis.
Since mast cells have been previously reported to produce IL-5 (5), we next evaluated whether these cells support lung metastasis by influencing recruitment of eosinophils to the lungs. We used c-kit mutant mice (c-kit W-sh mice), which have been shown to be deficient in mast cells (14) . Littermate WT mice were used as controls. First, we analyzed MBP-1-positive eosinophils in lung sections from c-kit W-sh mice and WT controls at 24 hours after IV injection of LLCs and found that eosinophils were markedly reduced in the lungs of c-kit W-sh mice ( Figure   4I ). In addition, we detected significantly fewer lung metastases in c-kit W-sh mice compared to WT mice after IV injection of LLC cells ( Figure 4J ). These studies suggest that c-kit + cells regulate the number of eosinophils in the lungs, possibly through local production of IL-5. 
Eosinophil-secreted CCL22 facilitates metastasis through local recruitment of regulatory T cells (Tregs)
In addition to exerting effects on eosinophils, IL-5 can affect lymphocyte fate (25) 
recruitment of Tregs to the lungs during metastasis. We measured chemokines that could support Tregs immigration into the lungs, including C-C motif chemokine ligands (CCL) 17, 20 and 22 (28) . Although we did not observe significant differences in CCL17 or CCL20 mRNA expression in lung tissue, CCL22 expression was markedly reduced in IL-5KO mice compared with WT mice (Figures C-E) . Since both Tregs and eosinophils were reduced in lungs of IL-5KO mice, we analyzed CCL22 expression by eosinophils. In vitro, mRNA expression of CCL22 by WT BMDEos was increased >30-fold after 4 hours of incubation with LLC-conditioned culture media ( Figure 6F ). Consistent with these findings, eosinophils isolated from lungs of WT mice at 24 hours after IV LLC injection expressed higher mRNA levels of CCL22 in comparison to lung eosinophils obtained from untreated WT mice ( Figure 6G ). In contrast, no differences in CCL22 mRNA expression were detected in lung macrophages from these mice following IV LLC cell injection (data not shown). prognosis (29) . Similarly, we reported that host-derived IL-5 is critical for formation of malignant pleural effusions induced by adenocarcinoma cells (10) . In the current study, we employed a variety of cancer cell lines and models to elucidate an important role for IL-5 in regulating a network of cellular interactions that sculpt the early metastatic niche in the lungs.
Our findings are in direct opposition to a study by Ikutani et Together, these findings suggest that the effects of IL-5 on primary tumors may be dependent on cellular origin and microenvironmental factors.
We detected greater numbers of sentinel eosinophils in the lungs of WT mice compared to IL-5KO mice under basal conditions and during lung metastasis. Like IL-5, eosinophils have been reported to be increased in some malignancies but the role of these cells in cancer remains controversial. A number of studies have shown anti-tumor effects of eosinophils in primary colorectal, gastrointestinal, head and neck cancers and melanoma (12, (32) (33) (34) (35) (36) reported that higher numbers of tumor infiltrating eosinophils correlate with better prognosis in NSCLC (37), several studies have indicated that accumulation of eosinophils is associated with aggressiveness of human NSCLC and indicative of poor prognosis (13, 38, 39) . In addition, the presence of eosinophils in oral squamous cell carcinoma is associated with poor prognosis (40, 41 ). In the current study, we found that adoptive transfer of eosinophils increases pulmonary metastasis in IL-5KO mice, indicating a pro-metastatic role for pulmonary eosinophils. In We found that tumor cells induce eosinophils to express markedly elevated levels of CCL22, which is a well-known chemokine for recruitment of Tregs (28) CAN-14-2379 studies, we found reduced CCL22 expression and fewer Tregs in the lungs of IL-5KO mice after LLC cell injection. In conjunction with these findings, we identified increased expression of the anti-tumor cytokine IFNγ by NK cells in IL-5KO mice, supporting the concept that Tregs are recruited to the lungs via eosinophil-derived CCL22 and suppress NK cell activation to facilitate survival of metastatic tumor cells.
Despite recent progress in deciphering the mechanisms that support lung tumor growth and progression, the efficacy of existing therapeutic strategies remains limited. Metastasis to the lungs account for the majority of deaths from lung cancer (47) . Since the "Seed and Soil" hypothesis was first proposed (48) , an ever-expanding body of evidence supports a critical role for the local microenvironment in supporting colonization of the lungs by metastatic tumor cells.
Therefore, understanding microenvironment factors supporting pulmonary metastasis would be beneficial for the development of novel cancer treatment strategies. Our current study indicates that IL-5 is involved in facilitating colonization of the lungs with tumor cells and suggests that IL-5 neutralizing therapy could be beneficial for the prevention of pulmonary metastases.
Humanized monoclonal antibodies against IL-5 (including Mepolizumab, GlaxoSmithKline) have been extensively studied in patients with asthma and eosinophil-related disorders and are well-tolerated (49) . Thus, this approach could be rapidly translated into studies designed to prevent metastasis of primary lung cancers and other cancers that frequently develop pulmonary metastasis.
In conclusion, our studies identify a novel immune/inflammatory network that supports 
